Catherine Esnault
About
In The Last Decade
Catherine Esnault
19 papers receiving 326 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 236
- Pharmacology 134
- Organic Chemistry 60
- Plant Science 57
- Genetics 32
Countries citing papers authored by Catherine Esnault
This map shows the geographic impact of Catherine Esnault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Esnault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Esnault more than expected).
Fields of papers citing papers by Catherine Esnault
This network shows the impact of papers produced by Catherine Esnault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Esnault. The network helps show where Catherine Esnault may publish in the future.
Co-authorship network of co-authors of Catherine Esnault
This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Esnault. A scholar is included among the top collaborators of Catherine Esnault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Esnault. Catherine Esnault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 8 | |
| 3 | 10 | |
| 4 | 50 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 18 | |
| 8 | 36 | |
| 9 | 36 | |
| 10 | Regulation of ppk expression and in vivo function of ppk in Streptomyces lividans TK24 | 1 |
| 11 | 62 | |
| 12 | 9 | |
| 13 | 2 | |
| 14 | 9 | |
| 15 | SV40 induced cellular immortalization: phenotypic changes associated with the loss of proliferative capacity in a conditionally immortalized cell line. | 10 |
| 16 | Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactions. | 13 |
| 17 | Rational design of bis-intercalating drugs as antitumour agents: importance of rigidity in the linking chain. | 2 |
| 18 | Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II. | 31 |
| 19 | Effects of new antitumor bifunctional intercalators derived from 7H-pyridocarbazole on sensitive and resistant L 1210 cells. | 33 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.